Ipratropium Bromide and Albuterol Sulfate
NDC 0487-0201, Ipratropium Bromide and Albuterol Sulfate, solution, from Nephron Pharmaceuticals Corporation.
- Product NDC
- 0487-0201
- Status
- Listed
- Labeler
- Nephron Pharmaceuticals Corporation
- Dosage form
- SOLUTION
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076749
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0487-0201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IPRATROPIUM BROMIDE.5 mg/3mL
- ALBUTEROL SULFATE3 mg/3mL
Pharmacologic classes
Adrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; beta2-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0487-0201-01 | 00487020101 | 30 POUCH in 1 CARTON (0487-0201-01) / 1 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE |
| 0487-0201-02 | 00487020102 | 30 POUCH in 1 CARTON (0487-0201-02) / 1 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE |
| 0487-0201-03 | 00487020103 | 6 POUCH in 1 CARTON (0487-0201-03) / 5 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE |
| 0487-0201-60 | 00487020160 | 12 POUCH in 1 CARTON (0487-0201-60) / 5 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ae35ec1f-526a-49bf-8262-c50e40190d1fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0487-0201NADAC price for package 00487020101
GET /v1/drugs/nadac/00487020101NADAC price for package 00487020103
GET /v1/drugs/nadac/00487020103NADAC price for package 00487020160
GET /v1/drugs/nadac/00487020160
Use it
Look up 0487-0201 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0487-0201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0487-0201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.